Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)

Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis

(2017) Sonali Paul et al.   HEPATOLOGY

Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study

(2017) Wai-Kay Seto et al.   HEPATOLOGY

Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis

(2017) Guofeng Chen et al.   HEPATOLOGY

Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals

(2017) Pamela S. Belperio et al.   HEPATOLOGY

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals

(2017) Ming-Lun Yeh et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection

(2017) Naoki Kawagishi et al.   JOURNAL OF HEPATOLOGY

Reactivation of hepatitis B virus from an isolated anti-HBc positive patient after eradication of hepatitis C virus with direct-acting antiviral agents

(2017) Tsuyoshi Suda et al.   JOURNAL OF HEPATOLOGY

Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma

(2017) Shengyu Huang et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management

(2017) Z. Liu et al.   JOURNAL OF VIRAL HEPATITIS

Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV

(2017) Eiichi Ogawa et al.   LIVER INTERNATIONAL

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana

(2017) Kathleen Ryan et al.   Open Forum Infectious Diseases

Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy

(2016) Wai-Kay Seto et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents’ era

(2016) Yutaka Tsukune et al.   ANNALS OF HEMATOLOGY

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment

(2016) C. S. Voican et al.   ANNALS OF ONCOLOGY

Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan

(2016) Wataru Fukuda et al.   ANNALS OF THE RHEUMATIC DISEASES

Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy

(2016) Stevan A. Gonzalez et al.   CLINICAL INFECTIOUS DISEASES

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor

(2016) C. Cerva et al.   CLINICAL MICROBIOLOGY AND INFECTION

HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously

(2016) Q. Y. CHEN et al.   EPIDEMIOLOGY AND INFECTION

HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea

(2016) Chung Hwan Jun et al.   Hepatology International

Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge

(2016) Anne De Monte et al.   JOURNAL OF CLINICAL VIROLOGY

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy

(2016) Kazuhiko Hayashi et al.   JOURNAL OF GASTROENTEROLOGY

First description of past Hepatitis B Virus infection acute reactivation occurring in a Human Immunodeficiency Virus infected patient as manifestation of immune reconstitution inflammatory syndrome

(2016) Clémence Lepelletier et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

SU-F-T-103: Analysis of Hepatitis B Virus Reactivation After Conformal Radiotherapy in Patients with Hepatocellular Carcinoma Using the Lyman NTCP Model

(2016) Z Li et al.   MEDICAL PHYSICS

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration

(2016) Christine M Hunt et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis

(2016) Sisi Yu et al.   International Journal of Clinical Pharmacy

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy

(2016) Qingqing Cai et al.   PLoS One

Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy

(2015) Chung-Il Wi et al.   Clinical Gastroenterology and Hepatology

Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir: Figure 1.

(2015) Jeffrey M. Collins et al.   CLINICAL INFECTIOUS DISEASES

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

(2015) K. Rajender Reddy et al.   GASTROENTEROLOGY

Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection

(2015) Hiroki Takayama et al.   HEPATOLOGY RESEARCH

Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase

(2015) Philippe Colson et al.   VIROLOGY

Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence

(2014) Tadashi Inuzuka et al.   JOURNAL OF HEPATOLOGY

Mutations associated with occult hepatitis B in HIV-positive South Africans

(2014) Eleanor A. Powell et al.   JOURNAL OF MEDICAL VIROLOGY

Limited Hepatitis B Virus Replication Space in the Chronically Hepatitis C Virus-Infected Liver

(2014) S. F. Wieland et al.   JOURNAL OF VIROLOGY

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt

(2014) Abeer Elkady   WORLD JOURNAL OF GASTROENTEROLOGY

HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient

(2013) Nicola Coppola et al.   JOURNAL OF CLINICAL VIROLOGY

Probable Corticosteroid-Induced Reactivation of Latent Hepatitis B Virus Infection in an HIV-Positive Patient Involving Immune Escape

(2012) Nora Martel et al.   JOURNAL OF INFECTIOUS DISEASES

Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: A case report and literature review

(2012) Rosa Ferreira et al.   Saudi Journal of Gastroenterology

Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy

(2012) Jessica P. Hwang et al.   Journal of Oncology Practice

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy

(2011) Andrea Costantini et al.   BMC INFECTIOUS DISEASES

Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy

(2011) Laura Ceccarelli et al.   JOURNAL OF INFECTION

Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption

(2010) S. Bagaglio et al.   INFECTION

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer

(2009) P. Borentain et al.   JOURNAL OF VIRAL HEPATITIS

Symptomatic Hepatitis B Virus (HBV) Reactivation despite Reduced Viral Fitness Is Associated with HBV Test and Immune Escape Mutations in an HIV‐Coinfected Patient

(2008) Cornelia Henke‐Gendo et al.   JOURNAL OF INFECTIOUS DISEASES

Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab

(2008) Masami Miyagawa et al.   JOURNAL OF MEDICAL VIROLOGY